“The Efficacy of Single Dose Palonosetron in Highly Emetogenic Chemotherapy Protocols Compared to Oral Aprepitant and Ondansetron”. 2022. Journal of Pharmacovigilance and Drug Research 3 (3): 28-39. https://doi.org/10.53411/jpadr.2022.3.3.06.